John Eikelboom
John Eikelboom
Unknown affiliation
Verified email at mcmaster.ca
Title
Cited by
Cited by
Year
Heart disease and stroke statistics—2015 update: a report from the American Heart Association
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...
circulation 131 (4), e29-e322, 2015
48387*2015
Dabigatran versus warfarin in patients with atrial fibrillation
SJ Connolly, MD Ezekowitz, S Yusuf, J Eikelboom, J Oldgren, A Parekh, ...
New England Journal of Medicine 361 (12), 1139-1151, 2009
119222009
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
New England Journal of Medicine 345 (7), 494-502, 2001
78762001
2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation developed …
Authors/Task Force Members, AJ Camm, GYH Lip, R De Caterina, ...
European heart journal 33 (21), 2719-2747, 2012
60332012
Edoxaban versus warfarin in patients with atrial fibrillation
RP Giugliano, CT Ruff, E Braunwald, SA Murphy, SD Wiviott, JL Halperin, ...
New England Journal of Medicine 369 (22), 2093-2104, 2013
41132013
Apixaban in patients with atrial fibrillation
SJ Connolly, J Eikelboom, C Joyner, HC Diener, R Hart, S Golitsyn, ...
New England Journal of Medicine 364 (9), 806-817, 2011
28282011
Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium
R Mehran, SV Rao, DL Bhatt, CM Gibson, A Caixeta, J Eikelboom, S Kaul, ...
Circulation 123 (23), 2736-2747, 2011
27542011
Executive summary: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines
GH Guyatt, EA Akl, M Crowther, DD Gutterman, HJ Schuünemann
Chest 141 (2 Suppl), 7S, 2012
2164*2012
Idarucizumab for dabigatran reversal
CV Pollack Jr, PA Reilly, J Eikelboom, S Glund, P Verhamme, ...
New England Journal of Medicine 373 (6), 511-520, 2015
17512015
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
B Bikdeli, MV Madhavan, D Jimenez, T Chuich, I Dreyfus, E Driggin, ...
Journal of the American college of cardiology 75 (23), 2950-2973, 2020
15372020
Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events
JW Eikelboom, J Hirsh, JI Weitz, M Johnston, Q Yi, S Yusuf
Circulation 105 (14), 1650-1655, 2002
15152002
Adverse impact of bleeding on prognosis in patients with acute coronary syndromes
JW Eikelboom, SR Mehta, SS Anand, C Xie, KA Fox, S Yusuf
Circulation 114 (8), 774-782, 2006
15122006
Homocysteine and vascular disease
GJ Hankey, JW Eikelboom
The lancet 354 (9176), 407-413, 1999
14161999
Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term …
JW Eikelboom, L Wallentin, SJ Connolly, M Ezekowitz, JS Healey, ...
Circulation 123 (21), 2363-2372, 2011
13242011
Rivaroxaban with or without aspirin in stable cardiovascular disease
JW Eikelboom, SJ Connolly, J Bosch, GR Dagenais, RG Hart, ...
New England Journal of Medicine 377 (14), 1319-1330, 2017
13102017
Homocyst (e) ine and cardiovascular disease: a critical review of the epidemiologic evidence
JW Eikelboom, E Lonn, J Genest Jr, G Hankey, S Yusuf
Annals of internal medicine 131 (5), 363-375, 1999
12781999
Dabigatran versus warfarin in patients with mechanical heart valves
JW Eikelboom, SJ Connolly, M Brueckmann, CB Granger, AP Kappetein, ...
N Engl J Med 369, 1206-1214, 2013
12392013
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis …
L Wallentin, S Yusuf, MD Ezekowitz, M Alings, M Flather, MG Franzosi, ...
The Lancet 376 (9745), 975-983, 2010
11842010
Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta‐analysis
SG Chu, RC Becker, PB Berger, DL Bhatt, JW Eikelboom, B Konkle, ...
Journal of Thrombosis and Haemostasis 8 (1), 148-156, 2010
10892010
CLINICAL PERSPECTIVE
SJ Connolly, J Pogue, J Eikelboom, G Flaker, P Commerford, ...
Circulation 118 (20), 2029-2037, 2008
989*2008
The system can't perform the operation now. Try again later.
Articles 1–20